NASDAQ · Medical - Healthcare Plans

CABR (CABR) Stock

$1.34 -17.08% NASDAQ: CABR Healthcare

Valuation

MetricValue
Price$1.34
Market Cap$12.14M
P/E Ratio-2.61
P/B Ratio8.81
P/S Ratio4178.08
EPS (TTM)$-0.46
52-Week High$1.65
52-Week Low$0.71
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-282.84%
ROA-300.00%
ROCE-300.00%
Gross Margin55.56%
Operating Margin-1408.07%
Net Margin-1489.49%
Debt/Equity0.03
Current Ratio13.16

Annual Financials (USD)

Metric20242025
Revenue—$0
Operating Profit—$-6.0M
Net Profit$-2.0M$-6.0M
EPS$-0.12$-0.46
Op Margin—-140807.0%

Balance Sheet (USD)

Metric2025
Total Assets$2.0M
Total Liabilities$0
Cash$2.0M
Borrowings$0

Latest News

Caring Brands Inks Expanded Five-Year Licensing Deal With SanPellegrino Cosmetics MT Newswires · Jun 1, 2026 Caring Brands Inc. and SanPellegrino Cosmetics Private Limited Announce Expanded Multi-Territory Licensing Agreement for Photocil and Hair Enzyme Booster GlobeNewswire · Jun 1, 2026

Cash Flow (USD)

Metric2025
Operating Cash Flow$-2.0M
Investing Cash Flow$0
Financing Cash Flow$0
Net Cash Flow$2.0M
Free Cash Flow$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-2.82
FCF Yield-9.61%
Quick Ratio13.09
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held23.10%
Institutions Held2.26%
Institutions Float Held2.94%
Institutional HolderSharesReport Date
Wells Fargo & Company72,4312026-03-31
Geode Capital Management, LLC58,8332026-03-31
Jane Street Group, LLC35,6682026-03-31
Xtx Topco Ltd20,7742026-03-31
Vanguard Capital Management LLC17,2512026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATGGFActinogen Medical Limited $0.00 — -7.07 $2.97M 0.00%
CLTEFClara Technologies Corp. $0.06 -91.43% -23.94 $3.60M 0.00%
DBCCFDecibel Cannabis Company Inc. $0.08 -0.08% -20.00 $44.71M 0.00%
ETSTEarth Science Tech, Inc. $0.15 +7.14% 12.20 $43.23M 0.00%
MDXHFMedX Health Corp $0.04 +0.00% -3.20 $14.10M 0.00%

About CABR

CABR is led by CEO Glynn Wilson, employs 4 people, headquartered in US, publicly traded since 2025.

CABR stock trades at $1.34 with a market capitalization of $12.14M. The stock is valued at a price-to-earnings (P/E) ratio of -2.61, price-to-book of 8.81, price-to-sales of 4178.08. Over the past 52 weeks the stock has ranged between $0.71 and $1.65, and currently trades 18.8% below its 52-week high.

On profitability, CABR generates a return on equity (ROE) of -282.84%, return on capital employed of -300.00%, an operating margin of -1408.07%, a net profit margin of -1489.49%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides